arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 8/2023 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Fat business: GLP-1 agonist semaglutide (WEGOVY) for weight reduction

    THERAPY FROM A CRITICAL VIEWPOINT

    Dual antiplatelet therapy or thrombolysis for “minor” stroke

    IN BRIEF

    New flu vaccines for the 2023-2024 season

    SULTANOL/VENTOLINE: drugs with rebate contracts without German package leaflet

    Misinformation on and overdose with food supplements

    Once again: misleading advertising for desvenlafaxine (DESVENEURAX) and NEUREXAN

    SIDE EFFECTS

    Migraine: hair loss with CGRP antibodies

    Increased risk of aspiration in patients treated with GLP-1 agonists?
    free

    e a-t ON THE INTERNET

    „Krebs-Scan“ [a cancer screening] insurance by HanseMerkur: insurer promotes “charlatanry”

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!